Thomas Klima
Operationeel Directeur bij BLUEBIRD BIO, INC.
Vermogen: 113 979 $ op 30-04-2024
Actieve functies van Thomas Klima
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BLUEBIRD BIO, INC. | Operationeel Directeur | 08-08-2022 | - |
Corporate Officer/Principal | 10-05-2021 | 08-08-2022 |
Loopbaan van Thomas Klima
Eerdere bekende functies van Thomas Klima
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GAMIDA CELL LTD. | Corporate Officer/Principal | 07-01-2019 | 01-12-2020 |
NAVIDEA BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 05-01-2015 | 08-03-2017 |
DENDREON CORPORATION | Verkoop & Marketing | 01-09-2009 | 01-09-2012 |
Opleiding van Thomas Klima
Western State College of Colorado | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Israël | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
GAMIDA CELL LTD. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Thomas Klima
- Ervaring